日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development of a novel meta-polygenic risk score for risk assessment and clinical manifestation prediction in systemic lupus erythematosus

开发一种新型的元多基因风险评分,用于系统性红斑狼疮的风险评估和临床表现预测

Qiao, Yingrui; Cao, Mengzhuo; Li, Mucong; Gai, Yixuan; Ding, Yufang; Li, Yutong; Qian, Junyan; Zhao, Jiuliang; Li, Caifeng; Yang, Xinzhuang; Li, Mengtao

Anti-mitochondrial M2 antibody links to cardiac involvement and immune-mediated inflammatory myopathy-like pathology in myositis

抗线粒体M2抗体与肌炎中的心脏受累和免疫介导的炎症性肌病样病理有关

Pang, Yiyun; Zhang, Lixi; Yao, Chen; Zhou, Shuang; Pang, Jie; Duan, Lihua; Meng, Juan; Yu, Chen; Wu, Chanyuan; Hu, Chaojun; Lai, Jinzhi; Wang, Yanhong; Tang, Mingwei; Qiao, Lin; Xu, Dong; Zhao, Jiuliang; Zeng, Xiaofeng; Tian, Zhuang; Li, Mengtao; Wang, Qian

Neuropsychiatric systemic lupus erythematosus subtypes identified by unsupervised clustering: A single-center cohort study

通过无监督聚类识别神经精神性系统性红斑狼疮亚型:一项单中心队列研究

Fang, Weiting; Zhao, Jiuliang; Xu, Dong; Wang, Ziqian; Li, Mengtao; Fan, Siyuan; Li, Tao; Xie, Manqing; Liu, Zeyu; You, Hui; Wang, Yanhong; Zhang, Shangzhu; Zeng, Xiaofeng

Rare TRAF5 coding variants in systemic lupus erythematosus patients aggravate pulmonary hypertension via endothelial dysfunction

系统性红斑狼疮患者中罕见的TRAF5编码变异可通过内皮功能障碍加重肺动脉高压。

Deng, Xiaoyue; Yuan, Tianyi; Qian, Junyan; Wang, Qian; Wang, Ran-Ran; Yang, Xinzhuang; Ma, Leyao; Li, Mucong; Du, Guanhua; Li, Mengtao; Zeng, Xiaofeng; Fang, Lianhua; Zhao, Jiuliang

Anti-CD38 monoclonal antibody CM313 for systemic lupus erythematosus: a randomized, double-blind, placebo-controlled phase Ib/IIa trial

抗CD38单克隆抗体CM313治疗系统性红斑狼疮:一项随机、双盲、安慰剂对照的Ib/IIa期试验

Zhao, Jiuliang; Lin, Changsong; Xie, Qibing; Shu, Qiang; Cui, Yang; Luo, Hui; Fan, Wenqiang; Huang, Anbin; Zhao, Yi; Fu, Zili; Xie, Changhao; Wu, Huaxiang; Yang, Niansheng; He, Lan; Feng, Ping; Zhang, Tiandong; Zhou, Huan; Liu, Wei; Hou, Qiaoyun; Mao, Xihua; Sun, Jing; Chen, Bo; Zeng, Xiaofeng

Applying Genetic Risk Score to Improve Risk Assessment of New-Onset Lupus Nephritis in Systemic Lupus Erythematosus: A Large-Scale Prospective Cohort Study

应用遗传风险评分改善系统性红斑狼疮新发狼疮性肾炎的风险评估:一项大规模前瞻性队列研究

Ding, Yufang; Li, Mucong; Bai, Wei; Qian, Junyan; Cao, Mengzhuo; Xu, Jian; Duan, Xinwang; Luo, Hui; Zhao, Cheng; Zhan, Feng; Yang, Min; Wu, Rui; Wu, Lijun; Chen, Zhen; Wei, Wei; Xu, Yang; Zhang, Shangzhu; Leng, Xiaomei; Wang, Qian; Tian, Xinping; Gao, Pei; Zeng, Xiaofeng; Yang, Xinzhuang; Li, Mengtao; Zhao, Jiuliang

Future atherosclerotic cardiovascular disease in systemic lupus erythematosus based on CSTAR (XXVIII): the effect of different antiphospholipid antibodies isotypes

基于CSTAR(XXVIII)研究的系统性红斑狼疮患者未来动脉粥样硬化性心血管疾病风险:不同抗磷脂抗体同种型的影响

Huang, Can; Ding, Yufang; Chen, Zhen; Wu, Lijun; Wei, Wei; Zhao, Cheng; Yang, Min; Lin, Shudian; Wang, Qian; Tian, Xinping; Zhao, Jiuliang; Li, Mengtao; Zeng, Xiaofeng

Remnant cholesterol predicts risk of recurrent thrombosis beyond LDL-cholesterol in patients with antiphospholipid syndrome

在抗磷脂综合征患者中,残余胆固醇比低密度脂蛋白胆固醇更能预测复发性血栓形成的风险。

Cai, Bin; Zhou, Yangzhong; Yang, Xinzhuang; Wang, Zhaoqing; Huang, Can; Xiao, Qingqing; Jiang, Hui; Zhao, Yuan; Tian, Xinping; Wang, Qian; Li, Guanqiao; Li, Mengtao; Zeng, Xiaofeng; Zhao, Jiuliang

Systemic lupus erythematosus related thrombotic microangiopathy: A retrospective study based on Chinese SLE Treatment and Research Group (CSTAR) registry

系统性红斑狼疮相关血栓性微血管病:基于中国系统性红斑狼疮治疗与研究组(CSTAR)注册登记的回顾性研究

Zhang, Yupei; Jiang, Nan; Chen, Zhen; Duan, Xinwang; Shi, Xiaofei; Li, Hongbin; Jiang, Zhenyu; Wang, Yuhua; Wang, Yanhong; Zhao, Jiuliang; Wang, Qian; Tian, Xinping; Li, Mengtao; Zeng, Xiaofeng

Comparative evaluation of three anti-dsDNA antibody detection methods in systemic lupus erythematosus: insights from a large monocentric cohort

系统性红斑狼疮中三种抗双链DNA抗体检测方法的比较评价:来自大型单中心队列研究的启示

Lu, Ruijing; Yu, Rui; Huang, Rong; Xue, Chiyuan; Song, Ning; Zhao, Jiuliang; Zeng, Xiaofeng; Hu, Chaojun